Literature DB >> 9311520

Recurrent respiratory distress associated with carbamazepine overdose.

F A Wilschut1, N A Cobben, F B Thunnissen, R J Lamers, E F Wouters, M Drent.   

Abstract

Acute interstitial pneumonia or diffuse alveolar damage is uncommon as an adverse reaction to carbamazepine therapy. We report the case of a 36 yr old woman, who developed respiratory failure after auto-intoxication with carbamazepine. Analysis, including bronchoalveolar lavage and lung tissue biopsy, suggested diffuse alveolar damage due to carbamazepine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311520     DOI: 10.1183/09031936.97.10092163

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  4 in total

1.  Clinical Features of Patients with Diffuse Alveolar Hemorrhage due to Negative-Pressure Pulmonary Edema.

Authors:  Damien Contou; Guillaume Voiriot; Michel Djibré; Vincent Labbé; Muriel Fartoukh; Antoine Parrot
Journal:  Lung       Date:  2017-04-28       Impact factor: 2.584

2.  Role of cytochrome P450 polymorphisms in the development of pulmonary drug toxicity: a case-control study in the Netherlands.

Authors:  Petal A H M Wijnen; Marjolein Drent; Patty J Nelemans; Petra M J C Kuijpers; Ger H Koek; Cees Neef; Guido R M M Haenen; Otto Bekers
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

3.  Building predictive in vitro pulmonary toxicity assays using high-throughput imaging and artificial intelligence.

Authors:  Jia-Ying Joey Lee; James Alastair Miller; Sreetama Basu; Ting-Zhen Vanessa Kee; Lit-Hsin Loo
Journal:  Arch Toxicol       Date:  2018-04-28       Impact factor: 5.153

4.  Post-ictal diffuse alveolar haemorrhage: clinical profile based on case reports.

Authors:  Jee Young You; James Stoller
Journal:  Respirol Case Rep       Date:  2022-04-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.